New extramural projects funded by MF Aubrey D.N.J. de Grey, Ph.D. Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK

Slides:

Advertisements

Similar presentations

Chief Science Officer, SENS Foundation

Advertisements

Dr Aubrey de Grey Chief Science Officer Rejuvenation technology: applying regenerative medicine to aging Aubrey D.N.J. de Grey, Ph.D. Chief Science Officer,

Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK

Dr Aubrey de Grey Chief Science Officer Repairing the aging brain: the SENS approach Aubrey D.N.J. de Grey, Ph.D. Chief Science Officer, SENS Foundation.

Special Topics in Modern Genetics: Epigenetics

The foreseeability of real anti-aging medicine: Faith, rational design, and our duty to abandon dogmatism just this once Aubrey D.N.J. de Grey Department.

Dr Aubrey de Grey Chief Science Officer Prospects for defeating aging altogether Aubrey D.N.J. de Grey, Ph.D. Chief Science Officer, SENS Foundation

Prospects for extending healthy life - a lot Aubrey D.N.J. de Grey, Ph.D. Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK

Prospects for defeating aging altogether Aubrey D.N.J. de Grey, Ph.D. Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK

International Student Exchange What is Exchange? Benefits of taking Part in the Exchange Program? Who is offering this? Three levels: University Faculty.

Frontiers In Biology Dr. K. S. Dulai Spring 2008

Ben M. Dunn, PhD. Distinguished Professor of Biochemistry & Molecular Biology Director, UF-HHMI Science for Life Program Director, IDS Program in Biochemistry.

Presentation #5 Scholarships Rotary International District 9630 Inc.

Jefferson Lab Programs Joint and bridge Faculty appointments Summer programs K-12 programs Impact.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Biology of Aging as a Basis for Future Treatment of Non-communicable Diseases and Health Care for the Aged Ilia Stambler, PhD Department of Science, Technology.

Is life extension an enhancement? Yes and no and why that’s useful

Strategic Plan for Enrollment Management Taskforce Presentation August 24, 2010 Recruitment Sub-group.

Involving Undergraduate Students in Research Isabelle Blain Vice-President, Research Grants & Scholarships, NSERC Canadian Society for Chemistry Société.

Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.

Funding Finding Grants & Tapping Campus Resources.

School of Microbiology Institute of Science

The aging phenotype: cellular aspects A&S Jim Lund.

Policies and Procedures for Summer Supplements on Federal Awards April

 Office of Undergraduate Research & Creative Activities.

Using Stem Cells to Treat Disease The first step: establish stem cell lines (large groups of the same cells) Next: turn on specific genes so that the stem.

Dr Aubrey de Grey Chief Science Officer Prospects for defeating aging altogether Aubrey D.N.J. de Grey, Ph.D. Chief Science Officer, SENS Foundation

Undergraduate UMBC Undergraduate Research is for YOU Get Started Today! How to Get Started in Research Wednesday, 9/9 | ENG023 | 12-1 Wednesday,

Grants & Sponsored Research at Methodist University Wendy Hustwit Grants and Sponsored Research Officer X7103 Trustees 216A.

AH Biology: Unit 1 Control of the Cell Cycle. The cell cycle: summary G1G1 G2G2 S Interphase M Cytokinesis Mitosis.

AH Biology: Unit 1 Apoptosis. What do falling leaves, the development of a mouse’s paw and a tadpole losing its tail all have in common?

The Prospect of Cell Replacement Therapy 王雪婷张硕

National Science Foundation Jan R. Taylor, Ph.D. Director of Research Programs Division of Science and Research WV Higher Education Policy Commission.

THERE ARE FOUR MAJOR BLOOD GROUPS DETERMINED BY THE PRESENCE OR ABSENCE OF TWO ANTIGENS (PROTEINS) –  A and B – on the surface of red blood cells: 

Benefits of being a member. Member benefits Subscription to professional quarterly journal ‘In Essence’

Gene Therapy. What is Gene Therapy? Gene Therapy is the insertion of genes into an individual’s cells and tissues to treat a disease. Gene Therapy is.

Have a positive role in cell division Have a negative role in cell division Have a role in the maintenance of DNA integrity Genes altered in cancer typically:

A segue is not just a dorky transportation device. Remember Mate Choice as an selective pressure in evolution?

What should actuaries be doing in the run-up to a post-aging world? Aubrey D.N.J. de Grey Department of Genetics, University of Cambridge Reprints, general.

Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,

“Vintage people” are possible, just like vintage cars Dr. Aubrey de Grey Methuselah Foundation, Cambridge, UK Website:

CELL DIFFERENTIATION.

31.3 IMMUNE SYSTEM KEY CONCEPT The immune system has many responses to pathogens and foreign cells.

The Circulatory System - Also known as the Cardiovascular system. Parts: 1. Heart 2. Blood 3. Blood Vessels.

SENS Research Foundation

Can we end aging? 林詩茵邱淑敏王雅佳袁樂宜.

Siderophores in Iron Metabolism: From Mechanism to Therapy Potential

Come and be a member of our website.

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

CELL DIFFERENTIATION.

How different types of cells look different!!

Many body systems work to produce nonspecific responses.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Foundation Fundraising

Introduction to Research at CPH

Undergraduate Research is for

Hungry for Mechanism in Hippo Signaling

KEY CONCEPT Genetics provides a basis for new medical treatments.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Immunity to infectious agents

Hypoxia-Inducible Factors, Stem Cells, and Cancer

Regulation of Organelle Biogenesis

KEY CONCEPT Genetics provides a basis for new medical treatments.

Volume 8, Issue 16, Pages R551-R553 (July 1998)

KEY CONCEPT Genetics provides a basis for new medical treatments.

Sickle Cell Disease.

KEY CONCEPT Genetics provides a basis for new medical treatments.

Presentation transcript:

New extramural projects funded by MF Aubrey D.N.J. de Grey, Ph.D. Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Website:

The good news, 1/1/09: still the old familiar table Damage rising with ageIt or its effects reversible by Cell loss, cell atrophyCell therapy, mainly Extracellular junkPhagocytosis by immune stimulation Extracellular crosslinksAGE-breaking molecules/enzymes Death-resistant cellsSuicide genes, immune stimulation Mitochondrial mutationsAllotopic expression of 13 proteins Intracellular junkTransgenic microbial hydrolases Nuclear [epi]mutations (only cancer matters) Telomerase/ALT gene deletion plus periodic stem cell reseeding

The bad news, 1/1/08 Damage rising with ageIt or its effects reversible by Cell loss, cell atrophyCell therapy, mainly Extracellular junkPhagocytosis by immune stimulation Extracellular crosslinksAGE-breaking molecules/enzymes Death-resistant cellsSuicide genes, immune stimulation Mitochondrial mutationsAllotopic expression of 13 proteins Intracellular junkTransgenic microbial hydrolases Nuclear [epi]mutations (only cancer matters) Telomerase/ALT gene deletion plus periodic stem cell reseeding Blue: MF funded from 2006 Red: MF-funded since 2006 Black: not MF-funded, 1/1/08

The good news, 1/1/08

The good news, 1/1/09 Damage rising with ageIt or its effects reversible by Cell loss, cell atrophyCell therapy, mainly Extracellular junkPhagocytosis by immune stimulation Extracellular crosslinksAGE-breaking molecules/enzymes Death-resistant cellsSuicide genes, immune stimulation Mitochondrial mutationsAllotopic expression of 13 proteins Intracellular junkTransgenic microbial hydrolases Nuclear [epi]mutations (only cancer matters) Telomerase/ALT gene deletion plus periodic stem cell reseeding Blue: MF funded from 2006 Red: MF-funded since 1/1/2008 Black: not MF-funded, 1/1/09

The new projects - Janko Nikolich-Zugich: two-part immune rejuvenation - Jan Vijg: epimutations in the cerebral cortex - The Gavrilovs: demographic consequences of SENS - Lenhard Rudolph: telomerase-negative blood (imminent)

What can YOU do in univ. labs? Well, if you’re an undergraduate…

How it works Within universities in the United States, students can perform independent research (typically lab projects in the form of advanced honors research projects). There is no cost for the student, but they must find a campus faculty member whose lab they may work in. By default, the successful approval of any student project brings onboard a full research lab and PhD mentor at no cost. Using this mechanism, MFURI utilizes undergraduate students to perform research to benefit the SENS agenda. As a way to generate student interest, MFURI has developed a lucrative scholarship program. Grants are also provided to cover basic costs of the lab work such as disposables and other necessary equipment/materials.

The bad news, 1/1/09 Damage rising with ageIt or its effects reversible by Cell loss, cell atrophyCell therapy, mainly Extracellular junkPhagocytosis by immune stimulation Extracellular crosslinksAGE-breaking molecules/enzymes Death-resistant cellsSuicide genes, immune stimulation Mitochondrial mutationsAllotopic expression of 13 proteins Intracellular junkTransgenic microbial hydrolases Nuclear [epi]mutations (only cancer matters) Telomerase/ALT gene deletion plus periodic stem cell reseeding Blue: MF funded from 2006 Red: partly MF-funded since 1/1/2008 Black: not MF-funded, 1/1/09

More bad news, 1/1/09